Anti-Flt-1, Mouse, Goat-Poly <Anti-VEGF Receptor 1>

データシート※最新のデータシートでない場合があります

• 商品コード：AF471
• メーカー：RSD
• 包装：100μg
• 価格： ¥105,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Matsuno H et al. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction. Blood 2002 Oct;100(7):2487-93
  Matsuno H et al
  2002/01/01
  
• 備考：
  Species: Mouse, Application: Neutralization
• 参照：
  

• No.： 2
• 文献情報：
  Silvestre JS et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ. Res. 2003 Jul;93(2):114-23
  Silvestre JS et al
  2003/01/01
  
• 備考：
  Application: Neutralization
• 参照：
  

• No.： 3
• 文献情報：
  Gerhardt H et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003 Jun;161(6):1163-77
  Gerhardt H et al
  2003/01/01
  
• 備考：
  Application: Neutralization
• 参照：
  

• No.： 4
• 文献情報：
  Shih SC et al. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J. Clin. Invest. 2003 Jul;112(1):50-7
  Shih SC et al
  2003/01/01
  
• 備考：
  Species: Mouse, Application: IHC Frozen, Sample type: Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
  Kanda S et al
  2004/01/01
  
• 備考：
  mouse IBE brain capillary and spleen epithelial cells
• 参照：
  

• No.： 6
• 文献情報：
  Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
  Usui T et al
  2004/01/01
  
• 備考：
  Application: Neutralization
• 参照：
  

• No.： 7
• 文献情報：
  Dikov MM et al. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J. Immunol. 2005 Jan;174(1):215-22
  Dikov MM et al
  2005/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Whole Cells
• 参照：
  

• No.： 8
• 文献情報：
  Gudehithlu KP et al. Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue. J. Lab. Clin. Med. 2005 Apr;145(4):194-203
  Gudehithlu KP et al
  2005/01/01
  
• 備考：
  rat granuloma
• 参照：
  

• No.： 9
• 文献情報：
  Wilgus TA et al. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am. J. Pathol. 2005 Nov;167(5):1257-66
  Wilgus TA et al
  2005/01/01
  
• 備考：
  Application: Neutralization
• 参照：
  

• No.： 10
• 文献情報：
  Nozaki M et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Invest. 2006 Feb;116(2):422-9
  Nozaki M et al
  2006/01/01
  
• 備考：
  mouse
• 参照：
  

• No.： 11
• 文献情報：
  Le Bras B et al. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat. Neurosci. 2006 Mar;9(3):340-8
  Le Bras B et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: IHC Frozen, Whole Tissue
• 参照：
  

• No.： 12
• 文献情報：
  Chen Y et al. Vascular endothelial growth factor promotes cardiomyocyte differentiation of embryonic stem cells. Am. J. Physiol. Heart Circ. Physiol. 2006 Oct;291(4):H1653-8
  Chen Y et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: Neutralization, Whole Cells
• 参照：
  

• No.： 13
• 文献情報：
  Marcellini M et al. Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am. J. Pathol. 2006 Aug;169(2):643-54
  Marcellini M et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: Neutralization, Sample type: Whole Cells
• 参照：
  

• No.： 14
• 文献情報：
  Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
  Cianfarani F et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: ELISA Development, Sample type: Homogenized Tissue - Protocol Included
• 参照：
  

• No.： 15
• 文献情報：
  Ambati BK et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006 Oct;443(7114):993-7
  Ambati BK et al
  2006/01/01
  
• 備考：
  Application: Neutralization, Sample Type: In Vivo
• 参照：
  

• No.： 16
• 文献情報：
  Mohamedali KA et al. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel. Cancer Res. 2006 Nov;66(22):10919-28
  Mohamedali KA et al
  2006/01/01
  
• 備考：
  Species: Mouse, Application: Neutralization, Sample type: Whole Cells
• 参照：
  

• No.： 17
• 文献情報：
  Muthig V et al. Upregulation of soluble vascular endothelial growth factor receptor 1 contributes to angiogenesis defects in the placenta of alpha 2B-adrenoceptor deficient mice. Circ. Res. 2007 Sep;101(7):682-91
  Muthig V et al
  2007/01/01
  
• 備考：
  Species: Mouse, Application: Western Blot, Sample type: Homogenized Tissue
• 参照：
  

• No.： 18
• 文献情報：
  Nishiguchi KM et al. The role of VEGF and VEGFR2/Flk1 in proliferation of retinal progenitor cells in murine retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2007 Sep;48(9):4315-20
  Nishiguchi KM et al
  2007/01/01
  
• 備考：
  Species: Mouse, Application: IHC Frozen, Neutralization, Sample type: Whole Tissue
• 参照：
  

• No.： 19
• 文献情報：
  Zhang Z et al. alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner. Blood 2008 Feb;111(4):1980-8
  Zhang Z et al
  2008/01/01
  
• 備考：
  Species: Mouse, Application: IHC Fresh, IHC Frozen, Neutralization, Western Blot, Whole Cells, Whole Tissue, Cell Lysates
• 参照：
  

• No.： 20
• 文献情報：
  Li Y et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J. Clin. Invest. 2008 Mar;118(3):913-23
  Li Y et al
  2008/01/01
  
• 備考：
  Species: Mouse, Rat, Application: Neutralization, In Vivo, Whole Cells
• 参照：
  

• No.： 21
• 文献情報：
  Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
  Marko SB et al
  2008/01/01
  
• 備考：
  Species: Rat, Application: IHC Fresh, Whole Cells, Whole Tissue
• 参照：
  

• No.： 22
• 文献情報：
  Eubank TD et al. Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res. 2009 Mar;69(5):2133-40
  Eubank TD et al
  2009/01/01
  
• 備考：
  Application: Neutralization, Sample Type: In Vivo
• 参照：
  

• No.： 23
• 文献情報：
  Shin JY et al. Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells. Cell. Immunol. 2009;256(1-2):72-8
  Shin JY et al
  2009/01/01
  
• 備考：
  Application: Neutralization, Sample Type: Whole Cells
• 参照：
  

• No.： 24
• 文献情報：
  Douglas NC et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology 2009 Aug;150(8):3845-54
  Douglas NC et al
  2009/01/01
  
• 備考：
  Application: IHC Frozen, Sample Type: tissue
• 参照：
  

• No.： 25
• 文献情報：
  Thi MM et al. Fluid flow-induced soluble vascular endothelial growth factor isoforms regulate actin adaptation in osteoblasts. J. Biol. Chem. 2010 Oct;285(40):30931-41
  Thi MM et al
  2010/01/01
  
• 備考：
  Application: Neutralization,Western Blot, Sample Type: Cell Lysates,Whole Cells
• 参照：
  

• No.： 26
• 文献情報：
  Roda JM et al. Hypoxia-inducible factor-2? regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis. J. Immunol. 2011 Aug;187(4):1970-6
  Roda JM et al
  2011/01/01
  
• 備考：
  Application: Neutralization, Sample Type: In Vivo
• 参照：
  

• No.： 27
• 文献情報：
  Schreurs MP et al. The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy. FASEB J. 2012 Jan;26(1):355-62
  Schreurs MP et al
  2012/01/01
  
• 備考：
  Application: Neutralization, Sample Type: In Vivo
• 参照：
  

• No.： 28
• 文献情報：
  Benedito R et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 2012 Apr;484(7392):110-4
  Benedito R et al
  2012/01/01
  
• 備考：
  Application: Immunoprecipitation, Sample Type: Tissue Lysate
• 参照：
  

• No.： 29
• 文献情報：
  Yao H et al. Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: involvement of &#x3B2;1 integrins. FASEB J. 2013 Apr;27(4):1532-48
  Yao H et al
  2013/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 30
• 文献情報：
  Carmi Y et al. The Role of IL-1&#x3B2; in the Early Tumor Cell-Induced Angiogenic Response. J. Immunol. 2013 Apr;190(7):3500-9
  Carmi Y et al
  2013/01/01
  
• 備考：
  Application: Flow Cytometry,IHC Frozen, Sample Type: Whole Cells,tissue
• 参照：
  

• No.： 31
• 文献情報：
  Hudson N et al. Differential apicobasal VEGF signaling at vascular blood-neural barriers. Dev. Cell 2014 Sep;30(5):541-52
  Hudson N et al
  2014/01/01
  
• 備考：
  Application: Neutralization, Sample Type: tissue section
• 参照：
  

• No.： 32
• 文献情報：
  Hou ST et al. Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage. Sci Rep 2015;5:7890
  Hou ST et al
  2015/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Whole Cells
• 参照：
  

• No.： 33
• 文献情報：
  Ola R et al. PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 2016 Nov;7:13650
  Ola R et al
  2016/01/01
  
• 備考：
  Application: IHC, Sample Type: Whole Tissue
• 参照：
  

• No.： 34
• 文献情報：
  Teixeira SC et al. Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy. Sci Rep 2017 Mar;7:44978
  Teixeira SC et al
  2017/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 35
• 文献情報：
  Zhao F et al. Construction of a vascularized bladder with autologous adipose-derived stromal vascular fraction cells combined with bladder acellular matrix via tissue engineering. J Tissue Eng ;10:2041731419891256
  Zhao F et al
  
• 備考：
  
• 参照：
  

• No.： 36
• 文献情報：
  Verma M et al. Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy. PLoS Genet 2019 12;15(12):e1008468
  Verma M et al
  2019/01/01
  
• 備考：
  
• 参照：